Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim ...

Regular fecal occult blood test (FOBT) screening for colorectal cancer is cost-effective in the general population, yet data are limited regarding the cost-effectiveness of FOBT screening in renal ...

The company hopes that its noninvasive assay is easier to use than stool-based fecal occult blood tests (FOBTs), currently the mainstay for early detection, but it does not see it replacing ...

Number of CRC screening claims in the US from 2013 to 2022. Data are expressed in numbers (N). CRC; colorectal cancer; FOBT; fecal occult blood test. This is an ASCO Meeting Abstract from the 2025 ...